October 19, 2007
Harvard Licensing Deal Reflects Its 'Public Mission'
Harvard University, one of the originators of a statement of how institutions can serve the public good while commercializing technology, has taken the message to heart.
A deal that the university has just signed for licensing a new vaccine technology, a top official says, reflects many of the principles espoused in the statement.
The invention involves a biochemical method of producing vaccines that could prove to be less complex than many existing approaches.
The
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review

-
Government

-
Advice



